Literature DB >> 16189651

Emission of membrane vesicles: roles in complement resistance, immunity and cancer.

David Pilzer1, Olivier Gasser, Oren Moskovich, Jurg A Schifferli, Zvi Fishelson.   

Abstract

Complement-mediated cell death is caused by C5b-9, the membrane attack complex (MAC) composed of the five complement proteins C5b, C6, C7, C8, and C9. Assembly of the C5b-9 complex initiates oligomerization of C9 and production of a transmembrane protein channel that inflicts damage to target cells. For protection, cells eliminate the MAC from their surface either by ectocytosis (direct emission of membrane vesicles) or by endocytosis (internalization). The process of ectosome release is rapid and involves cytosolic Ca(2+) and activation of protein kinases, such as protein kinase C (PKC) and extracellular signal-regulated protein kinase (ERK). Recently, the involvement of mortalin (also known as GRP75 and mitochondrial hsp70) in MAC elimination has been suggested. Extracellular application of antibodies directed to mortalin increases cell sensitivity to MAC-mediated lysis. Release of membrane vesicles is ubiquitous and enhanced in apoptotic or tumor cells and upon cell activation. Composition of the ectosomes (also often referred to as microparticles) membrane proteins and lipids appears to be different from those of the original plasma membrane, indicating involvement of a selective sorting process during ectosome formation. Exosomes (unlike ectosomes) are membrane vesicles generated by endocytosis, endosome sorting into perinuclear multivesicular bodies (MVB) and exocytosis of MVBs. Exosomes appear to be different in size and composition from ectosomes. Exosome-associated MAC has also been described. Although research on ectosomes and exosomes is still limited, physiological roles in coagulation, vascular functions, angiogenesis, wound healing and development have been attributed to these shed membrane vesicles. On the other hand, there are indications that elevated levels of ectosomes and exosomes may predispose to morbidity. Membrane vesicles released by cells exposed to complement MAC may play roles in health and disease beyond protection from cell death.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16189651     DOI: 10.1007/s00281-005-0004-1

Source DB:  PubMed          Journal:  Springer Semin Immunopathol        ISSN: 0344-4325


  103 in total

1.  More on: cellular microparticles: what are they bad or good for?

Authors:  Y S Ahn; W Jy; J J Jimenez; L L Horstman
Journal:  J Thromb Haemost       Date:  2004-07       Impact factor: 5.824

2.  Sublytic complement attack protects tumor cells from lytic doses of antibody and complement.

Authors:  Y Reiter; A Ciobotariu; Z Fishelson
Journal:  Eur J Immunol       Date:  1992-05       Impact factor: 5.532

3.  On the destruction of erythrocytes and other cells by antibody and complement.

Authors:  M M MAYER
Journal:  Cancer Res       Date:  1961-10       Impact factor: 12.701

4.  Elimination of terminal complement complexes in the plasma membrane of nucleated cells: influence of extracellular Ca2+ and association with cellular Ca2+.

Authors:  D F Carney; C H Hammer; M L Shin
Journal:  J Immunol       Date:  1986-07-01       Impact factor: 5.422

Review 5.  The membrane attack complex of complement.

Authors:  H J Müller-Eberhard
Journal:  Annu Rev Immunol       Date:  1986       Impact factor: 28.527

6.  Activated platelets release two types of membrane vesicles: microvesicles by surface shedding and exosomes derived from exocytosis of multivesicular bodies and alpha-granules.

Authors:  H F Heijnen; A E Schiel; R Fijnheer; H J Geuze; J J Sixma
Journal:  Blood       Date:  1999-12-01       Impact factor: 22.113

7.  Complement-induced vesiculation and exposure of membrane prothrombinase sites in platelets of paroxysmal nocturnal hemoglobinuria.

Authors:  T Wiedmer; S E Hall; T L Ortel; W H Kane; W F Rosse; P J Sims
Journal:  Blood       Date:  1993-08-15       Impact factor: 22.113

8.  Ultrastructural studies of complement mediated cell death: a biological reaction model to plasma membrane injury.

Authors:  J C Papadimitriou; C B Drachenberg; M L Shin; B F Trump
Journal:  Virchows Arch       Date:  1994       Impact factor: 4.064

9.  Proteomic and biochemical analyses of human B cell-derived exosomes. Potential implications for their function and multivesicular body formation.

Authors:  Richard Wubbolts; Rachel S Leckie; Peter T M Veenhuizen; Guenter Schwarzmann; Wiebke Möbius; Joerg Hoernschemeyer; Jan-Willem Slot; Hans J Geuze; Willem Stoorvogel
Journal:  J Biol Chem       Date:  2003-01-07       Impact factor: 5.157

10.  Release of spectrin-free vesicles from human erythrocytes during ATP depletion. I. Characterization of spectrin-free vesicles.

Authors:  H U Lutz; S C Liu; J Palek
Journal:  J Cell Biol       Date:  1977-06       Impact factor: 10.539

View more
  73 in total

Review 1.  Microparticles as mediators and biomarkers of rheumatic disease.

Authors:  David S Pisetsky; Anirudh J Ullal; Julie Gauley; Tony C Ning
Journal:  Rheumatology (Oxford)       Date:  2012-03-07       Impact factor: 7.580

Review 2.  Ectosomes as modulators of inflammation and immunity.

Authors:  S Sadallah; C Eken; J A Schifferli
Journal:  Clin Exp Immunol       Date:  2010-10-29       Impact factor: 4.330

3.  Blebbing confers resistance against cell lysis.

Authors:  E B Babiychuk; K Monastyrskaya; S Potez; A Draeger
Journal:  Cell Death Differ       Date:  2010-07-02       Impact factor: 15.828

Review 4.  On the brotherhood of the mitochondrial chaperones mortalin and heat shock protein 60.

Authors:  Custer C Deocaris; Sunil C Kaul; Renu Wadhwa
Journal:  Cell Stress Chaperones       Date:  2006       Impact factor: 3.667

5.  Microparticles in stored red blood cells as potential mediators of transfusion complications.

Authors:  Wenche Jy; Marco Ricci; Sherry Shariatmadar; Orlando Gomez-Marin; Lawrence H Horstman; Yeon S Ahn
Journal:  Transfusion       Date:  2011-04       Impact factor: 3.157

6.  Upregulation of CD59: potential mechanism of accommodation in a large animal model.

Authors:  Adam D Griesemer; Masayoshi Okumi; Akira Shimizu; Shannon Moran; Yoshinori Ishikawa; Justin Iorio; J Scott Arn; Kazuhiko Yamada
Journal:  Transplantation       Date:  2009-05-15       Impact factor: 4.939

7.  Fas death receptor enhances endocytic membrane traffic converging into the Golgi region.

Authors:  Mauro Degli Esposti; Julien Tour; Sihem Ouasti; Saska Ivanova; Paola Matarrese; Walter Malorni; Roya Khosravi-Far
Journal:  Mol Biol Cell       Date:  2008-11-26       Impact factor: 4.138

8.  Regulation of perforin lysis: implications for protein disulfide isomerase proteins.

Authors:  David L Tamang; Bryce N Alves; Viki Elliott; Doug Redelman; Renu Wadhwa; Stephanie A Fraser; Dorothy Hudig
Journal:  Cell Immunol       Date:  2009-01-14       Impact factor: 4.868

9.  Endothelial expression of autocrine VEGF upon the uptake of tumor-derived microvesicles containing oncogenic EGFR.

Authors:  Khalid Al-Nedawi; Brian Meehan; Robert S Kerbel; Anthony C Allison; Janusz Rak
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-20       Impact factor: 11.205

Review 10.  Role of C5b-9 complement complex and response gene to complement-32 (RGC-32) in cancer.

Authors:  Sonia I Vlaicu; Cosmin A Tegla; Cornelia D Cudrici; Jacob Danoff; Hassan Madani; Adam Sugarman; Florin Niculescu; Petru A Mircea; Violeta Rus; Horea Rus
Journal:  Immunol Res       Date:  2013-05       Impact factor: 2.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.